Search research articles
Contact Us
Filters
Showing results (141-150 of 224) with videos related to
Page
of 23
Sort By:
American Journal of Hematology
|
November 18, 2024
The role of allogeneic stem cell transplantation in acute myeloid leukemia with translocation t(8;16)(p11;p13)
Ann-Kristin Schmälter, Myriam Labopin, Jurjen Versluis, et al.
Leukemia & Lymphoma
|
January 16, 2019
Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation
Deborah Christen, Kristina Sohlbach, Stephan K Metzelder, et al.
Journal of Cancer Research and Clinical Oncology
|
June 11, 2014
A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels
Manuel Tonigold, Annette Rossmann, Marie Meinold, et al.
Cells
|
April 12, 2024
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1
Kai Zhao, Madita Braun, Leonie Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2007
Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study
Michael Herold, Antje Haas, Stefanie Srock, et al.
British Journal of Haematology
|
March 5, 2025
The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML
Sebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, et al.
Cancer Investigation
|
September 20, 2006
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
Ulrich J M Mey, Katjana S Orlopp, Dimitri Flieger, et al.
Haematologica
|
December 4, 2019
Cloning and characterization of a novel druggable fusion kinase in acute myeloid leukemia
Christian Michel, Elisabeth K.M. Mack, Christopher-Nils Mais, et al.
Frontiers in Oncology
|
April 7, 2022
Point Mutations in the <i>FLT3</i>-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant <i>KMT2A</i>-PTD
Sebastian Stasik, Michael Kramer, Sven Zukunft, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2006
Randomized trial of single compared with tandem high-dose chemotherapy followed by autologous stem-cell transplantation in patients with chemotherapy-sensitive metastatic breast cancer
Nicolaus Kröger, Markus Frick, Oleg Gluz, et al.
Page
of 23
Search research articles
Search
Showing results (141-150 of 224) with videos related to
Sort By:
Page
of 23
American Journal of Hematology
|
November 18, 2024
The role of allogeneic stem cell transplantation in acute myeloid leukemia with translocation t(8;16)(p11;p13)
Ann-Kristin Schmälter, Myriam Labopin, Jurjen Versluis, et al.
Leukemia & Lymphoma
|
January 16, 2019
Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation
Deborah Christen, Kristina Sohlbach, Stephan K Metzelder, et al.
Journal of Cancer Research and Clinical Oncology
|
June 11, 2014
A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels
Manuel Tonigold, Annette Rossmann, Marie Meinold, et al.
Cells
|
April 12, 2024
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1
Kai Zhao, Madita Braun, Leonie Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2007
Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study
Michael Herold, Antje Haas, Stefanie Srock, et al.
British Journal of Haematology
|
March 5, 2025
The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML
Sebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, et al.
Cancer Investigation
|
September 20, 2006
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
Ulrich J M Mey, Katjana S Orlopp, Dimitri Flieger, et al.
Haematologica
|
December 4, 2019
Cloning and characterization of a novel druggable fusion kinase in acute myeloid leukemia
Christian Michel, Elisabeth K.M. Mack, Christopher-Nils Mais, et al.
Frontiers in Oncology
|
April 7, 2022
Point Mutations in the <i>FLT3</i>-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant <i>KMT2A</i>-PTD
Sebastian Stasik, Michael Kramer, Sven Zukunft, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2006
Randomized trial of single compared with tandem high-dose chemotherapy followed by autologous stem-cell transplantation in patients with chemotherapy-sensitive metastatic breast cancer
Nicolaus Kröger, Markus Frick, Oleg Gluz, et al.
Page
of 23